Permax (Pergolide Mesylate) and Dostinex (Cabergoline) were medications used to treat mainly patients with Parkinson’s Disease and Restless Leg Syndrome. Unfortunately, like many other recent medications, these drugs and their generic equivalents were withdrawn from the market for causing damage to patients’ heart valves. Specifically, studies have shown that Permax and Dostinex affect the mitral, aortic, and tricuspid heart valves by causing varying degrees of heart valve regurgitation (the backward flow of blood across the heart valves), otherwise known as valvular heart disease. This occurrence causes the heart to work harder to pump blood through the heart valves, which results in users becoming short of breath and more easily fatigued when participating in physical activity. This damage to the heart valves can also lead to congestive heart failure, heart valve replacement, or death.
An ultrasound of the chest, called an echocardiogram, is the best way to determine if heart valve damage or regurgitation exists. Unless a patient exhibits signs and symptoms of valvular heart disease or has had previous heart valve issues, echocardiograms are rarely ordered by treating physicians. Due to the relative scarcity of echocardiograms being used, there are many patients that have used Permax or Dostinex, but are unaware of the damage that their heart valves may have.
Fortunately, for many of our Permax and Dostinex clients, they were able to have echocardiograms performed identifying varying degrees of damage to their heart valve, which resulted in immediate treatment. It has also led to several lawsuits being filed around the country involving the damage that these drugs have caused. Currently, the first Permax case in the country is set for trial in Miami in March, 2010. The second Permax case in the country is set for trial in November, 2010. Trial dates for a handful of other Permax and Dostinex cases are currently pending. We continue to gather evidence regarding the dangers of these drugs. We expect these trials will hold these companies responsible for the injuries they have caused these clients.
If you need additional information on this subject, contact Navan Ward in our firm at 800-898-2034 or by email at Navan.Ward@beasleyallen.com.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.